These independent studies collectively provide evidence that the expression levels of ADAMTSL4, SEMA5B, ADAMTS15, THBS2, SPON1 and THBS1 have the potential to serve as diagnostic and prognostic targets for the management of BL. This evidence concerns the gene ADAMTS15 and Burkitt lymphoma.